Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy | Eye
Crossover to Half-dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy patients (SPECS) - ScienceDirect
Half-dose photodynamic therapy for serous non-neovascular retinal pigment epithelial detachment. - Document - Gale Academic OneFile
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy - Ophthalmology
Real-World Experience with Half-Time Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy | Journal of Ocular Pharmacology and Therapeutics
Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy | British Journal of Ophthalmology
Half-dose PDT outperforms subthreshold micropulse laser for central serous chorioretinopathy - American Academy of Ophthalmology
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization | Scientific Reports
Half-dose Versus Half-time Photodynamic Therapy for Central Serous Chorioretinopathy. | Semantic Scholar
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy | SpringerLink
Current Therapeutic Approaches to Chronic Central Serous Chorioretinopathy
JCM | Free Full-Text | Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy | HTML
Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial - American Journal of Ophthalmology
One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy | BMC Ophthalmology | Full Text
Five emerging treatments show mixed results
Changes in PrOs length after PDT in irradiated area in half-fluence and... | Download Table
Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group | British Journal of Ophthalmology
Photodynamic Therapy for Chorioretinal Diseases: A Practical Approach | SpringerLink
JCM | Free Full-Text | Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half -Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3 - American Journal of Ophthalmology
Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study | PLOS ONE
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy - Ophthalmology
Half-dose PDT for chronic central serous chorioretinopathy. Summary of... | Download Scientific Diagram
Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients - Ophthalmology Retina
